Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beth Seidenberg
Biotech
Capsida ready to make its gene therapy play
As an endocrinologist, Bob Cuddihy, M.D., felt stymied with the lack of advances in his field.
Kevin Dunleavy
Apr 29, 2021 5:15am
Horizon alums unveil Acelyrin to accelerate promising drugs
Dec 15, 2020 4:45am
Harper, Seidenberg's Westlake reels in $500M across 2 funds
Dec 15, 2020 4:45am
Why Amgen vets Harper and Seidenberg set up their own VC shop
Feb 18, 2020 10:52am
ArsenalBio joins next-gen cell therapy field with $85M A round
Oct 17, 2019 7:00am
Sean Harper and Beth Seidenberg unite to run $320M VC fund
Sep 5, 2018 7:00am
